Detalhe da pesquisa
1.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570876
2.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588409
3.
Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy.
Cancer
; 126(9): 1837-1855, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073653
4.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
5.
Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy.
Br J Haematol
; 189(2): 313-317, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804715
6.
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
Blood Rev
; 61: 101101, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258362
7.
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
Blood Adv
; 7(21): 6630-6638, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595053
8.
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Blood Adv
; 7(21): 6381-6394, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171397
9.
Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies.
Clin Lymphoma Myeloma Leuk
; 20(10): 661-667, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576502
10.
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.
Blood Adv
; 4(2): 253-262, 2020 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945157
11.
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
JCI Insight
; 3(8)2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669947
12.
Richter's Transformation in the Era of Kinase Inhibitor Therapy: A Review.
Clin Lymphoma Myeloma Leuk
; 17(1): 1-6, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27707629
13.
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.
PET Clin
; 11(3): 209-18, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27321026
14.
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
JCI Insight
; 4(4)2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30830874